Showing 1 - 4 results of 4 for search 'Akiyuki Suzuki' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Akiyuki Suzuki
Showing 1 - 4 results of 4 for search 'Akiyuki Suzuki', query time: 0.03s Refine Results
  1. 1
    Does Industry‐Conducted All‐Case Surveillance of Newly Approved Oncology Drugs Contribute to the Revision of Package Inserts in Japan?

    Does Industry‐Conducted All‐Case Surveillance of Newly Approved Oncology Drugs Contribute to the Revision of Package Inserts in Japan? by Akiyuki Suzuki, Hitoshi Sato, Yasutsuna Sasaki

    Published 2019-09-01
    Get full text
    Article
  2. 2
    Assessment of Captive Environment for Oriental Small-Clawed Otters (<i>Aonyx cinereus</i>) in Otter Cafés in Japan

    Assessment of Captive Environment for Oriental Small-Clawed Otters (<i>Aonyx cinereus</i>) in Otter Cafés in Japan by Nana Ushine, Ayu Kamitaki, Akiyuki Suzuki, Shin-Ichi Hayama

    Published 2024-08-01
    Get full text
    Article
  3. 3
    Enantioselective total synthesis of (+)-aureol via BF3•Et2O-promoted rearrangement/cylization reaction of (+)-arenarol

    Enantioselective total synthesis of (+)-aureol via BF3•Et2O-promoted rearrangement/cylization reaction of (+)-arenarol by Mari Nakatani, Masahiko Nakamura, Akiyuki Suzuki, Takamasa Fuchikami, Munenori Inoue, Tadashi Katoh

    Published 2003-06-01
    Get full text
    Article
  4. 4
    Prediction of relative change in free nerve growth factor following subcutaneous administration of tanezumab, a novel monoclonal antibody to nerve growth factor

    Prediction of relative change in free nerve growth factor following subcutaneous administration of tanezumab, a novel monoclonal antibody to nerve growth factor by Satoshi Shoji, Akiyuki Suzuki, Parya Nouri, Chun‐Hua Cai, Puneet Gaitonde, Scott Marshall

    Published 2023-09-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs